MValve Technologies' Convertible Note Round

MValve Technologies raised a round of funding on July 06, 2014. Investors include Boston Scientific Corporation.

MValve technologies is an Israeli-American company dedicated to providing a solution to the unmet clinical need of Mitral Regurgitation - an abnormal reversal of blood flow from the heart's left ventr…

Articles about MValve Technologies' Convertible Note Round: